Abbot Financial Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.15M | Sell |
14,504
-92
| -0.6% | -$20.4K | 1.32% | 18 |
|
|
2025
Q4 | $3.34M | Sell |
14,596
-50
| -0.3% | -$11.4K | 1.38% | 16 |
|
|
2025
Q3 | $3.39M | Sell |
14,646
-100
| -0.7% | -$20.4K | 1.45% | 15 |
|
|
2025
Q2 | $2.74M | Sell |
14,746
-325
| -2% | -$60.4K | 1.26% | 18 |
|
|
2025
Q1 | $3.16M | Sell |
15,071
-150
| -1% | -$29.2K | 1.64% | 13 |
|
|
2024
Q4 | $2.7M | Sell |
15,221
-350
| -2% | -$64.3K | 1.35% | 19 |
|
|
2024
Q3 | $3.07M | Sell |
15,571
-115
| -0.7% | -$21.5K | 1.55% | 17 |
|
|
2024
Q2 | $2.69M | Sell |
15,686
-520
| -3% | -$86.1K | 1.44% | 17 |
|
|
2024
Q1 | $2.95M | Hold |
16,206
| – | – | 1.63% | 14 |
|
|
2023
Q4 | $2.51M | Sell |
16,206
-450
| -3% | -$65.6K | 1.51% | 19 |
|
|
2023
Q3 | $2.48M | Sell |
16,656
-500
| -3% | -$73.4K | 1.67% | 16 |
|
|
2023
Q2 | $2.31M | Sell |
17,156
-500
| -3% | -$73.3K | 1.48% | 19 |
|
|
2023
Q1 | $2.81M | Sell |
17,656
-200
| -1% | -$30.6K | 1.89% | 14 |
|
|
2022
Q4 | $2.89M | Sell |
17,856
-906
| -5% | -$139K | 1.97% | 14 |
|
|
2022
Q3 | $2.52M | Sell |
18,762
-3,200
| -15% | -$459K | 1.79% | 15 |
|
|
2022
Q2 | $3.36M | Sell |
21,962
-200
| -0.9% | -$30.6K | 2.03% | 9 |
|
|
2022
Q1 | $3.59M | Sell |
22,162
-550
| -2% | -$79.9K | 1.75% | 13 |
|
|
2021
Q4 | $3.08M | Sell |
22,712
-140
| -0.6% | -$16.5K | 1.37% | 24 |
|
|
2021
Q3 | $2.46M | Buy |
22,852
+100
| +0.4% | +$11.4K | 1.12% | 27 |
|
|
2021
Q2 | $2.56M | Buy |
22,752
+480
| +2% | +$54.1K | 1.12% | 27 |
|
|
2021
Q1 | $2.41M | Buy |
22,272
+400
| +2% | +$42.8K | 1.09% | 26 |
|
|
2020
Q4 | $2.34M | Sell |
21,872
-650
| -3% | -$62.5K | 1.35% | 27 |
|
|
2020
Q3 | $1.97M | Sell |
22,522
-151
| -0.7% | -$14.2K | 1.28% | 30 |
|
|
2020
Q2 | $2.23M | Sell |
22,673
-23
| -0.1% | -$2.02K | 1.53% | 24 |
|
|
2020
Q1 | $1.73M | Sell |
22,696
-200
| -0.9% | -$17K | 1.41% | 26 |
|
|
2019
Q4 | $2.03M | Buy |
22,896
+1,254
| +6% | +$104K | 1.28% | 30 |
|
|
2019
Q3 | $1.64M | Sell |
21,642
-517
| -2% | -$35.4K | 1.17% | 30 |
|
|
2019
Q2 | $1.61M | Sell |
22,159
-450
| -2% | -$35.4K | 1.17% | 30 |
|
|
2019
Q1 | $1.82M | Hold |
22,609
| – | – | 1.41% | 25 |
|
|
2018
Q4 | $2.08M | Sell |
22,609
-400
| -2% | -$35.2K | 1.84% | 19 |
|
|
2018
Q3 | $2.18M | Sell |
23,009
-494
| -2% | -$46.8K | 1.62% | 19 |
|
|
2018
Q2 | $2.18M | Sell |
23,503
-300
| -1% | -$29.3K | 1.73% | 15 |
|
|
2018
Q1 | $2.25M | Sell |
23,803
-525
| -2% | -$57.7K | 1.81% | 16 |
|
|
2017
Q4 | $2.35M | Sell |
24,328
-800
| -3% | -$75.4K | 1.88% | 16 |
|
|
2017
Q3 | $2.3M | Sell |
25,128
-150
| -0.6% | -$11.4K | 1.92% | 16 |
|
|
2017
Q2 | $1.83M | Buy |
+25,278
| New | +$1.7M | 1.64% | 21 |
|
Other funds holding ABBV
VCM
VPM
Abbot Financial Management's ABBV Position: Q1 2026 in Review
Abbot Financial Management reduced its AbbVie (ABBV) stake by 0.63% in Q1 2026, selling an estimated $20.4K and leaving 14,504 shares worth $3.15M. The position accounts for 1.32% of the portfolio, ranked #18.
Abbot Financial Management first reported a position in ABBV in Q2 2017 and has held it in 36 quarters since. The position peaked at $3.59M in Q1 2022. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Abbot Financial Management held 14,504 shares of AbbVie worth $3.15M as of Q1 2026.
- Abbot Financial Management sold 92 AbbVie shares in Q1 2026, an estimated $20.4K.
- AbbVie made up 1.32% of Abbot Financial Management's portfolio in Q1 2026, its #18 holding.
- Abbot Financial Management first reported a position in AbbVie in Q2 2017 and has held it in 36 quarters since.
- Abbot Financial Management's AbbVie position peaked at $3.59M in Q1 2022.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Abbot Financial Management's 13F filing for Q1 2026, filed 13 May 2026.